AstraZeneca, Janssen Pharma To Co-Market Prostate Drug In Japan
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca and Johnson & Johnson's Japan unit, Janssen Pharmaceuticals KK have agreed to collaborate on marketing Zytiga (abiraterone) already awaiting market approval.